The spread of coronavirus could DOUBLE during influenza season

A new study led by the Max Planck Institute for Infection Biology in Berlin, found between a two-fold and a 2.5-fold increase in COVID-19 cases during the period in which the flu was co-circulating.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news

Related Links:

Immunological adaptations in pregnancy allow maternal tolerance of the semi-allogeneic fetus but also increase maternal susceptibility to infection. At implantation, the endometrial stroma, glands, arteries and immune cells undergo anatomical and functional transformation to create the decidua, the specialized secretory endometrium of pregnancy. The maternal decidua and the invading fetal trophoblast constitute a dynamic junction that facilitates a complex immunological dialogue between the two. The decidual and peripheral immune systems together assume a pivotal role in regulating the critical balance between tolerance an...
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research
Children get sick; it’s part of life. They catch colds, they get fevers, they throw up and get diarrhea. Most of the time, it’s nothing at all. But this year, as we struggle through the COVID-19 pandemic, every sniffle will be complicated. The problem is, the symptoms of COVID-19 can be not just mild, but similar to the symptoms of all the common illnesses kids get all the time. Symptoms can include fever, even a mild one cough (that you don’t have another clear reason for) breathing difficulty sore throat or runny nose (that you don’t have another clear reason for) loss of taste or smell headache ...
Source: Harvard Health Blog - Category: Consumer Health News Authors: Tags: Adolescent health Children's Health Cold and Flu Coronavirus and COVID-19 Parenting Source Type: blogs
An improved understanding of human T cell-mediated immunity in COVID-19 is important for optimizing therapeutic and vaccine strategies. Experience with influenza shows that infection primes CD8+ T cell memory to peptides presented by common HLA types like HLA-A2, which enhances recovery and diminishes clinical severity upon reinfection. Stimulating peripheral blood...
Source: Proceedings of the National Academy of Sciences - Category: Science Authors: Tags: Coronavirus (COVID-19) Biological Sciences Source Type: research
cbsoptanon.onScriptsReady(function(cmp){cmp.ot.targetingAllowed(function(a){if(a) AnvatoPlayer("p0").init({"mcp":"cbs","width":"100%","height":"100%","video":"4743798","autoplay":false,"titleVisible":false,"accessKey":"EZqvRyKE7qmqDflDPXIw6U7kKZEA0Vx7","accessControl":{"preview":false},"pInstance":"p0","plugins":{"heartbeat":{"account":"cbslocal-global-unified","publisherId":"cbslocal","jobId...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - Category: Consumer Health News Authors: Tags: Boston News Health Syndicated CBSN Boston Flu Vaccine Source Type: news
Publication date: Available online 26 September 2020Source: Biosensors and BioelectronicsAuthor(s): Hyeong Rae Kim, Sanggwon An, Jungho Hwang
Source: Biosensors and Bioelectronics - Category: Biotechnology Source Type: research
Abstract Coronavirus disease 2019 (COVID-19) surveillance, in Brazil, initiated shortly after its description, in China. Our aim was to detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and additional pathogens in samples from the initial phase of the outbreak in Brazil, from late February to late March. From 707 samples analysed, 29 (4.1%) were SARS-CoV-2 positive. Fever and cough were their most prevalent symptoms. Co-detection of rhinovirus was observed in 2 (6.9%) cases. Additional pathogens were identified in 66.1% of the SARS-CoV-2 negative cases, mainly rhinovirus and influenza A(H1N1)pdm0...
Source: Memorias do Instituto Oswaldo Cruz - Category: Infectious Diseases Authors: Tags: Mem Inst Oswaldo Cruz Source Type: research
The recent pandemic of coronavirus infectious illness 2019 (COVID19) triggered by SARS-CoV-2 has rapidly spread around the globe, generating in severe events an acute, highly lethal pneumonia and death. In the past two hitherto similar CoVs, the severe acute respiratory syndrome CoV (SARS-CoV-1) and Middle East respiratory syndrome CoV (MERS-CoV) also gained universal attention as they produced clinical symptoms similar to those of SARS-CoV-2 utilizing angiotensin-converting enzyme 2 (ACE2) receptor and dipeptidyl peptidase 4 (DPP4) to go into the cells. COVID-19 may also present with overtly neurological symptoms. The pro...
Source: Frontiers in Neurology - Category: Neurology Source Type: research
The objective of this review was to collate information regarding the potential of plants and natural products to inhibit coronavirus and targets associated with infection in humans and to highlight known drugs, which may have potential activity against SARS-CoV-2. Due to the similarity in the RNA genome, main proteases, and primary host receptor between SARS-CoV and SARS-CoV-2, a review was conducted on plants and secondary metabolites, which have shown activity against SARS-CoV. Numerous scientific reports on the potential of plants and secondary metabolites against SARS-CoV infection were found, providing important info...
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research
Respiratory infections can be caused by many viruses such as, influenza and coronavirus. If a novel virus gains the capacity to spread globally with sustained human-to-human transmission, a pandemic can occur (Qatar National Cancer Registry, 2014). Influenza epidemics are happening every year. In the past, several influenza pandemics have occurred such as, the 1918 pandemic (H1N1 virus), the 1957-1958 pandemic (H2N2 virus), 1968 pandemic (H3N2 virus), and the recent 2009 H1N1 pandemic (H1N1pdm09 virus) (Past Pandemics USA, 2018).
Source: International Journal of Infectious Diseases - Category: Infectious Diseases Authors: Tags: Review Source Type: research
The Maryland company, which has never brought a vaccine to market, has started its Phase 3 trial in the United Kingdom, with plans to begin in the United States in October.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Novavax Inc Clinical Trials Vaccination and Immunization Coronavirus (2019-nCoV) Johnson & Moderna Inc Pfizer Inc Research Influenza Drugs (Pharmaceuticals) Great Britain United States Source Type: news
More News: Biology | Coronavirus | COVID-19 | Health | Influenza | Study